img

Global and India Short-acting EPO Drugs Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Short-acting EPO Drugs Market Report & Forecast 2024-2034

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
The global Short-acting EPO Drugs revenue was US$ 9180 million in 2022 and is forecast to a readjusted size of US$ 13830 million by 2029 with a CAGR of 6.2% during the forecast period (2024-2034).
In India, the Short-acting EPO Drugs revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2024-2034).
Short-acting EPO drugs have a wide range of applications in the market, primarily used for treating anemia-related conditions such as anemia associated with chronic kidney disease and in the supportive treatment of leukemia patients. The market size is substantial and continues to grow, particularly in Asian and European regions. Sales have been on the rise, reflecting increasing patient demand and benefiting from ongoing advancements in medical technology. In the future, short-acting EPO drugs are poised for further development, potentially encompassing the treatment of more anemia-related conditions and expanding their market share through innovative therapies and market expansion efforts.
This report focuses on global and India Short-acting EPO Drugs market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2024, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Short-acting EPO Drugs will continue to grow rapidly in the future.
Global Short-acting EPO Drugs Scope and Market Size
Short-acting EPO Drugs market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Short-acting EPO Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Short-acting EPO Drugs market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.



By Company


Amgen
Johnson & Johnson
Roche
Kyowa Kirin
LG Chem
Daewoong Pharmaceutical
Wockhardt
CJ Healthcare
3SBio
Kexing Biopharm
Harbin Pharmaceutical Group
Beijing Four Rings Bio-Pharmaceutical
Segment by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others

Segment by Application


Anemia
Kidney Disorders
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Short-acting EPO Drugs definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Short-acting EPO Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Short-acting EPO Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Short-acting EPO Drugs sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Short-acting EPO Drugs Product Introduction
1.2 Global Short-acting EPO Drugs Outlook 2018 VS 2022 VS 2029
1.2.1 Global Short-acting EPO Drugs Sales in US$ Million for the Year 2018-2029
1.2.2 Global Short-acting EPO Drugs Sales in Volume for the Year 2018-2029
1.3 India Short-acting EPO Drugs Outlook 2018 VS 2022 VS 2029
1.3.1 India Short-acting EPO Drugs Sales in US$ Million for the Year 2018-2029
1.3.2 India Short-acting EPO Drugs Sales in Volume for the Year 2018-2029
1.4 Short-acting EPO Drugs Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Short-acting EPO Drugs in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Short-acting EPO Drugs Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Short-acting EPO Drugs Market Dynamics
1.5.1 Short-acting EPO Drugs Industry Trends
1.5.2 Short-acting EPO Drugs Market Drivers
1.5.3 Short-acting EPO Drugs Market Challenges
1.5.4 Short-acting EPO Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Short-acting EPO Drugs by Type
2.1 Short-acting EPO Drugs Market Segment by Type
2.1.1 Epoetin-alfa
2.1.2 Epoetin-beta
2.1.3 Darbepoetin-alfa
2.1.4 Others
2.2 Global Short-acting EPO Drugs Market Size by Type
2.2.1 Global Short-acting EPO Drugs Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Short-acting EPO Drugs Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Short-acting EPO Drugs Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Short-acting EPO Drugs Market Size by Type
2.3.1 India Short-acting EPO Drugs Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Short-acting EPO Drugs Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Short-acting EPO Drugs Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Short-acting EPO Drugs by Application
3.1 Short-acting EPO Drugs Market Segment by Application
3.1.1 Anemia
3.1.2 Kidney Disorders
3.1.3 Others
3.2 Global Short-acting EPO Drugs Market Size by Application
3.2.1 Global Short-acting EPO Drugs Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Short-acting EPO Drugs Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Short-acting EPO Drugs Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Short-acting EPO Drugs Market Size by Application
3.3.1 India Short-acting EPO Drugs Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Short-acting EPO Drugs Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Short-acting EPO Drugs Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Short-acting EPO Drugs Competitor Landscape by Company
4.1 Global Short-acting EPO Drugs Market Size by Company
4.1.1 Global Key Manufacturers of Short-acting EPO Drugs, Ranked by Revenue (2022)
4.1.2 Global Short-acting EPO Drugs Revenue by Manufacturer (2018-2024)
4.1.3 Global Short-acting EPO Drugs Sales by Manufacturer (2018-2024)
4.1.4 Global Short-acting EPO Drugs Price by Manufacturer (2018-2024)
4.2 Global Short-acting EPO Drugs Concentration Ratio (CR)
4.2.1 Short-acting EPO Drugs Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Short-acting EPO Drugs in 2022
4.2.3 Global Short-acting EPO Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Short-acting EPO Drugs, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Short-acting EPO Drugs, Product Offered and Application
4.5 Global Key Manufacturers of Short-acting EPO Drugs, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Short-acting EPO Drugs Market Size by Company
4.7.1 Key Players of Short-acting EPO Drugs in India, Ranked by Revenue (2022)
4.7.2 India Short-acting EPO Drugs Revenue by Players (2018-2024)
4.7.3 India Short-acting EPO Drugs Sales by Players (2018-2024)
5 Global Short-acting EPO Drugs Market Size by Region
5.1 Global Short-acting EPO Drugs Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Short-acting EPO Drugs Market Size in Volume by Region (2018-2029)
5.2.1 Global Short-acting EPO Drugs Sales in Volume by Region: 2018-2024
5.2.2 Global Short-acting EPO Drugs Sales in Volume Forecast by Region (2024-2029)
5.3 Global Short-acting EPO Drugs Market Size in Value by Region (2018-2029)
5.3.1 Global Short-acting EPO Drugs Sales in Value by Region: 2018-2024
5.3.2 Global Short-acting EPO Drugs Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Short-acting EPO Drugs Market Size YoY Growth 2018-2029
6.2 Americas Short-acting EPO Drugs Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Short-acting EPO Drugs Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Short-acting EPO Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Short-acting EPO Drugs Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Short-acting EPO Drugs Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Short-acting EPO Drugs Market Size YoY Growth 2018-2029
7.2 EMEA Short-acting EPO Drugs Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Short-acting EPO Drugs Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Short-acting EPO Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Short-acting EPO Drugs Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Short-acting EPO Drugs Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Short-acting EPO Drugs Market Size YoY Growth 2018-2029
8.2 China Short-acting EPO Drugs Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Short-acting EPO Drugs Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Short-acting EPO Drugs Market Size YoY Growth 2018-2029
9.2 APAC Short-acting EPO Drugs Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Short-acting EPO Drugs Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Short-acting EPO Drugs Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Short-acting EPO Drugs Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Short-acting EPO Drugs Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Amgen
10.1.1 Amgen Company Information
10.1.2 Amgen Description and Business Overview
10.1.3 Amgen Short-acting EPO Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Amgen Short-acting EPO Drugs Products Offered
10.1.5 Amgen Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Description and Business Overview
10.2.3 Johnson & Johnson Short-acting EPO Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Johnson & Johnson Short-acting EPO Drugs Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Description and Business Overview
10.3.3 Roche Short-acting EPO Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Roche Short-acting EPO Drugs Products Offered
10.3.5 Roche Recent Development
10.4 Kyowa Kirin
10.4.1 Kyowa Kirin Company Information
10.4.2 Kyowa Kirin Description and Business Overview
10.4.3 Kyowa Kirin Short-acting EPO Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Kyowa Kirin Short-acting EPO Drugs Products Offered
10.4.5 Kyowa Kirin Recent Development
10.5 LG Chem
10.5.1 LG Chem Company Information
10.5.2 LG Chem Description and Business Overview
10.5.3 LG Chem Short-acting EPO Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 LG Chem Short-acting EPO Drugs Products Offered
10.5.5 LG Chem Recent Development
10.6 Daewoong Pharmaceutical
10.6.1 Daewoong Pharmaceutical Company Information
10.6.2 Daewoong Pharmaceutical Description and Business Overview
10.6.3 Daewoong Pharmaceutical Short-acting EPO Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Daewoong Pharmaceutical Short-acting EPO Drugs Products Offered
10.6.5 Daewoong Pharmaceutical Recent Development
10.7 Wockhardt
10.7.1 Wockhardt Company Information
10.7.2 Wockhardt Description and Business Overview
10.7.3 Wockhardt Short-acting EPO Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Wockhardt Short-acting EPO Drugs Products Offered
10.7.5 Wockhardt Recent Development
10.8 CJ Healthcare
10.8.1 CJ Healthcare Company Information
10.8.2 CJ Healthcare Description and Business Overview
10.8.3 CJ Healthcare Short-acting EPO Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 CJ Healthcare Short-acting EPO Drugs Products Offered
10.8.5 CJ Healthcare Recent Development
10.9 3SBio
10.9.1 3SBio Company Information
10.9.2 3SBio Description and Business Overview
10.9.3 3SBio Short-acting EPO Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 3SBio Short-acting EPO Drugs Products Offered
10.9.5 3SBio Recent Development
10.10 Kexing Biopharm
10.10.1 Kexing Biopharm Company Information
10.10.2 Kexing Biopharm Description and Business Overview
10.10.3 Kexing Biopharm Short-acting EPO Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Kexing Biopharm Short-acting EPO Drugs Products Offered
10.10.5 Kexing Biopharm Recent Development
10.11 Harbin Pharmaceutical Group
10.11.1 Harbin Pharmaceutical Group Company Information
10.11.2 Harbin Pharmaceutical Group Description and Business Overview
10.11.3 Harbin Pharmaceutical Group Short-acting EPO Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Harbin Pharmaceutical Group Short-acting EPO Drugs Products Offered
10.11.5 Harbin Pharmaceutical Group Recent Development
10.12 Beijing Four Rings Bio-Pharmaceutical
10.12.1 Beijing Four Rings Bio-Pharmaceutical Company Information
10.12.2 Beijing Four Rings Bio-Pharmaceutical Description and Business Overview
10.12.3 Beijing Four Rings Bio-Pharmaceutical Short-acting EPO Drugs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Beijing Four Rings Bio-Pharmaceutical Short-acting EPO Drugs Products Offered
10.12.5 Beijing Four Rings Bio-Pharmaceutical Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Short-acting EPO Drugs Industry Chain Analysis
11.2 Short-acting EPO Drugs Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Short-acting EPO Drugs Production Mode & Process
11.4 Short-acting EPO Drugs Sales and Marketing
11.4.1 Short-acting EPO Drugs Sales Channels
11.4.2 Short-acting EPO Drugs Distributors
11.5 Short-acting EPO Drugs Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Short-acting EPO Drugs CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
Table 2. Short-acting EPO Drugs Market Trends
Table 3. Short-acting EPO Drugs Market Drivers
Table 4. Short-acting EPO Drugs Market Challenges
Table 5. Short-acting EPO Drugs Market Restraints
Table 6. Global Short-acting EPO Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. India Short-acting EPO Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Short-acting EPO Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. India Short-acting EPO Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Manufacturers of Short-acting EPO Drugs, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Short-acting EPO Drugs Revenue by Manufacturer, (US$ Million), 2018-2024
Table 12. Global Short-acting EPO Drugs Revenue Share by Manufacturer, 2018-2024
Table 13. Global Short-acting EPO Drugs Sales by Manufacturer, (K Units), 2018-2024
Table 14. Global Short-acting EPO Drugs Sales Share by Manufacturer, 2018-2024
Table 15. Global Short-acting EPO Drugs Price by Manufacturer (2018-2024) & (US$/Unit)
Table 16. Global Short-acting EPO Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Short-acting EPO Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short-acting EPO Drugs as of 2022)
Table 18. Global Key Manufacturers of Short-acting EPO Drugs, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Short-acting EPO Drugs, Product Offered and Application
Table 20. Global Key Manufacturers of Short-acting EPO Drugs, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Short-acting EPO Drugs in India, Ranked by Revenue (2022) & (US$ million)
Table 23. India Short-acting EPO Drugs Revenue by Players, (US$ Million), (2018-2024)
Table 24. India Short-acting EPO Drugs Revenue Share by Players, (2018-2024)
Table 25. India Short-acting EPO Drugs Sales by Players, (K Units), (2018-2024)
Table 26. India Short-acting EPO Drugs Sales Share by Players, (2018-2024)
Table 27. Global Short-acting EPO Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 28. Global Short-acting EPO Drugs Sales in Volume by Region (2018-2024) & (K Units)
Table 29. Global Short-acting EPO Drugs Sales in Volume Forecast by Region (2024-2029) & (K Units)
Table 30. Global Short-acting EPO Drugs Sales in Value by Region (2018-2024) & (US$ Million)
Table 31. Global Short-acting EPO Drugs Sales in Value Forecast by Region (2024-2029) & (US$ Million)
Table 32. Americas Short-acting EPO Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. Americas Short-acting EPO Drugs Sales in Value by Country (2018-2024) & (US$ Million)
Table 34. Americas Short-acting EPO Drugs Sales in Value by Country (2024-2029) & (US$ Million)
Table 35. Americas Short-acting EPO Drugs Sales in Volume by Country (2018-2024) & (K Units)
Table 36. Americas Short-acting EPO Drugs Sales in Volume by Country (2024-2029) & (K Units)
Table 37. EMEA Short-acting EPO Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. EMEA Short-acting EPO Drugs Sales in Value by Country (2018-2024) & (US$ Million)
Table 39. EMEA Short-acting EPO Drugs Sales in Value by Country (2024-2029) & (US$ Million)
Table 40. EMEA Short-acting EPO Drugs Sales in Volume by Country (2018-2024) & (K Units)
Table 41. EMEA Short-acting EPO Drugs Sales in Volume by Country (2024-2029) & (K Units)
Table 42. APAC Short-acting EPO Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. APAC Short-acting EPO Drugs Sales in Value by Country (2018-2024) & (US$ Million)
Table 44. APAC Short-acting EPO Drugs Sales in Value by Country (2024-2029) & (US$ Million)
Table 45. APAC Short-acting EPO Drugs Sales in Volume by Country (2018-2024) & (K Units)
Table 46. APAC Short-acting EPO Drugs Sales in Volume by Country (2024-2029) & (K Units)
Table 47. Amgen Company Information
Table 48. Amgen Description and Business Overview
Table 49. Amgen Short-acting EPO Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 50. Amgen Short-acting EPO Drugs Product
Table 51. Amgen Recent Development
Table 52. Johnson & Johnson Company Information
Table 53. Johnson & Johnson Description and Business Overview
Table 54. Johnson & Johnson Short-acting EPO Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 55. Johnson & Johnson Short-acting EPO Drugs Product
Table 56. Johnson & Johnson Recent Development
Table 57. Roche Company Information
Table 58. Roche Description and Business Overview
Table 59. Roche Short-acting EPO Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 60. Roche Short-acting EPO Drugs Product
Table 61. Roche Recent Development
Table 62. Kyowa Kirin Company Information
Table 63. Kyowa Kirin Description and Business Overview
Table 64. Kyowa Kirin Short-acting EPO Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 65. Kyowa Kirin Short-acting EPO Drugs Product
Table 66. Kyowa Kirin Recent Development
Table 67. LG Chem Company Information
Table 68. LG Chem Description and Business Overview
Table 69. LG Chem Short-acting EPO Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 70. LG Chem Short-acting EPO Drugs Product
Table 71. LG Chem Recent Development
Table 72. Daewoong Pharmaceutical Company Information
Table 73. Daewoong Pharmaceutical Description and Business Overview
Table 74. Daewoong Pharmaceutical Short-acting EPO Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 75. Daewoong Pharmaceutical Short-acting EPO Drugs Product
Table 76. Daewoong Pharmaceutical Recent Development
Table 77. Wockhardt Company Information
Table 78. Wockhardt Description and Business Overview
Table 79. Wockhardt Short-acting EPO Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 80. Wockhardt Short-acting EPO Drugs Product
Table 81. Wockhardt Recent Development
Table 82. CJ Healthcare Company Information
Table 83. CJ Healthcare Description and Business Overview
Table 84. CJ Healthcare Short-acting EPO Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 85. CJ Healthcare Short-acting EPO Drugs Product
Table 86. CJ Healthcare Recent Development
Table 87. 3SBio Company Information
Table 88. 3SBio Description and Business Overview
Table 89. 3SBio Short-acting EPO Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 90. 3SBio Short-acting EPO Drugs Product
Table 91. 3SBio Recent Development
Table 92. Kexing Biopharm Company Information
Table 93. Kexing Biopharm Description and Business Overview
Table 94. Kexing Biopharm Short-acting EPO Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 95. Kexing Biopharm Short-acting EPO Drugs Product
Table 96. Kexing Biopharm Recent Development
Table 97. Harbin Pharmaceutical Group Company Information
Table 98. Harbin Pharmaceutical Group Description and Business Overview
Table 99. Harbin Pharmaceutical Group Short-acting EPO Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 100. Harbin Pharmaceutical Group Short-acting EPO Drugs Product
Table 101. Harbin Pharmaceutical Group Recent Development
Table 102. Beijing Four Rings Bio-Pharmaceutical Company Information
Table 103. Beijing Four Rings Bio-Pharmaceutical Description and Business Overview
Table 104. Beijing Four Rings Bio-Pharmaceutical Short-acting EPO Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 105. Beijing Four Rings Bio-Pharmaceutical Short-acting EPO Drugs Product
Table 106. Beijing Four Rings Bio-Pharmaceutical Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Short-acting EPO Drugs Customers List
Table 110. Short-acting EPO Drugs Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Short-acting EPO Drugs Product Picture
Figure 2. Global Short-acting EPO Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Short-acting EPO Drugs Market Size 2018-2029 (US$ Million)
Figure 4. Global Short-acting EPO Drugs Sales 2018-2029 (K Units)
Figure 5. India Short-acting EPO Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 6. India Short-acting EPO Drugs Market Size 2018-2029 (US$ Million)
Figure 7. India Short-acting EPO Drugs Sales 2018-2029 (K Units)
Figure 8. India Short-acting EPO Drugs Market Share in Global, in Value (US$ Million) 2018-2029
Figure 9. India Short-acting EPO Drugs Market Share in Global, in Volume (K Units) 2018-2029
Figure 10. Short-acting EPO Drugs Report Years Considered
Figure 11. Product Picture of Epoetin-alfa
Figure 12. Product Picture of Epoetin-beta
Figure 13. Product Picture of Darbepoetin-alfa
Figure 14. Product Picture of Others
Figure 15. Global Short-acting EPO Drugs Market Share by Type in 2022 & 2029
Figure 16. Global Short-acting EPO Drugs Sales in Value by Type (2018-2029) & (US$ Million)
Figure 17. Global Short-acting EPO Drugs Sales Market Share in Value by Type (2018-2029)
Figure 18. Global Short-acting EPO Drugs Sales by Type (2018-2029) & (K Units)
Figure 19. Global Short-acting EPO Drugs Sales Market Share in Volume by Type (2018-2029)
Figure 20. Global Short-acting EPO Drugs Price by Type (2018-2029) & (US$/Unit)
Figure 21. India Short-acting EPO Drugs Market Share by Type in 2022 & 2029
Figure 22. India Short-acting EPO Drugs Sales in Value by Type (2018-2029) & (US$ Million)
Figure 23. India Short-acting EPO Drugs Sales Market Share in Value by Type (2018-2029)
Figure 24. India Short-acting EPO Drugs Sales by Type (2018-2029) & (K Units)
Figure 25. India Short-acting EPO Drugs Sales Market Share in Volume by Type (2018-2029)
Figure 26. India Short-acting EPO Drugs Price by Type (2018-2029) & (US$/Unit)
Figure 27. Product Picture of Anemia
Figure 28. Product Picture of Kidney Disorders
Figure 29. Product Picture of Others
Figure 30. Global Short-acting EPO Drugs Market Share by Application in 2022 & 2029
Figure 31. Global Short-acting EPO Drugs Sales in Value by Application (2018-2029) & (US$ Million)
Figure 32. Global Short-acting EPO Drugs Sales Market Share in Value by Application (2018-2029)
Figure 33. Global Short-acting EPO Drugs Sales by Application (2018-2029) & (K Units)
Figure 34. Global Short-acting EPO Drugs Sales Market Share in Volume by Application (2018-2029)
Figure 35. Global Short-acting EPO Drugs Price by Application (2018-2029) & (US$/Unit)
Figure 36. India Short-acting EPO Drugs Market Share by Application in 2022 & 2029
Figure 37. India Short-acting EPO Drugs Sales in Value by Application (2018-2029) & (US$ Million)
Figure 38. India Short-acting EPO Drugs Sales Market Share in Value by Application (2018-2029)
Figure 39. India Short-acting EPO Drugs Sales by Application (2018-2029) & (K Units)
Figure 40. India Short-acting EPO Drugs Sales Market Share in Volume by Application (2018-2029)
Figure 41. India Short-acting EPO Drugs Price by Application (2018-2029) & (US$/Unit)
Figure 42. Americas Short-acting EPO Drugs Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 43. Americas Short-acting EPO Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 44. Americas Short-acting EPO Drugs Sales by Type (2018-2029) & (K Units)
Figure 45. Americas Short-acting EPO Drugs Sales Market Share in Volume by Type (2018-2029)
Figure 46. Americas Short-acting EPO Drugs Sales by Application (2018-2029) & (K Units)
Figure 47. Americas Short-acting EPO Drugs Sales Market Share in Volume by Application (2018-2029)
Figure 48. United States Short-acting EPO Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 49. Canada Short-acting EPO Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 50. Mexico Short-acting EPO Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Short-acting EPO Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 52. EMEA Short-acting EPO Drugs Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 53. EMEA Short-acting EPO Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 54. EMEA Short-acting EPO Drugs Sales by Type (2018-2029) & (K Units)
Figure 55. EMEA Short-acting EPO Drugs Sales Market Share in Volume by Type (2018-2029)
Figure 56. EMEA Short-acting EPO Drugs Sales by Application (2018-2029) & (K Units)
Figure 57. EMEA Short-acting EPO Drugs Sales Market Share in Volume by Application (2018-2029)
Figure 58. Europe Short-acting EPO Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 59. Middle East Short-acting EPO Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 60. Africa Short-acting EPO Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 61. China Short-acting EPO Drugs Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 62. China Short-acting EPO Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 63. China Short-acting EPO Drugs Sales by Type (2018-2029) & (K Units)
Figure 64. China Short-acting EPO Drugs Sales Market Share in Volume by Type (2018-2029)
Figure 65. China Short-acting EPO Drugs Sales by Application (2018-2029) & (K Units)
Figure 66. China Short-acting EPO Drugs Sales Market Share in Volume by Application (2018-2029)
Figure 67. APAC Short-acting EPO Drugs Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 68. APAC Short-acting EPO Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 69. APAC Short-acting EPO Drugs Sales by Type (2018-2029) & (K Units)
Figure 70. APAC Short-acting EPO Drugs Sales Market Share in Volume by Type (2018-2029)
Figure 71. APAC Short-acting EPO Drugs Sales by Application (2018-2029) & (K Units)
Figure 72. APAC Short-acting EPO Drugs Sales Market Share in Volume by Application (2018-2029)
Figure 73. Japan Short-acting EPO Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 74. South Korea Short-acting EPO Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 75. China Taiwan Short-acting EPO Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 76. Southeast Asia Short-acting EPO Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 77. India Short-acting EPO Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 78. Short-acting EPO Drugs Value Chain
Figure 79. Short-acting EPO Drugs Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries